000 01408 a2200337 4500
005 20250515035931.0
264 0 _c20060912
008 200609s 0 0 eng d
022 _a1527-7755
024 7 _a10.1200/JCO.2005.05.3959
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aScharf, Orit
245 0 0 _aAdverse event reporting in publications compared with sponsor database for cancer clinical trials.
_h[electronic resource]
260 _bJournal of clinical oncology : official journal of the American Society of Clinical Oncology
_cAug 2006
300 _a3933-8 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article
650 0 4 _aAdverse Drug Reaction Reporting Systems
650 0 4 _aAntineoplastic Agents
_xadverse effects
650 0 4 _aClinical Trials, Phase II as Topic
_xeconomics
650 0 4 _aDatabases, Factual
650 0 4 _aHumans
650 0 4 _aNational Institutes of Health (U.S.)
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aProduct Surveillance, Postmarketing
650 0 4 _aPublication Bias
650 0 4 _aResearch Support as Topic
650 0 4 _aUnited States
700 1 _aColevas, A Dimitrios
773 0 _tJournal of clinical oncology : official journal of the American Society of Clinical Oncology
_gvol. 24
_gno. 24
_gp. 3933-8
856 4 0 _uhttps://doi.org/10.1200/JCO.2005.05.3959
_zAvailable from publisher's website
999 _c16507511
_d16507511